Waskyra – Patient Worthy

Gene Therapy Revolution: Waskyra Offers Life-Changing Hope for Wiskott-Aldrich Syndrome Patients

Post author:Bree Clare
Post published:November 25, 2025
Post category:Wiskott-Aldrich Syndrome

A groundbreaking achievement in genetic medicine has emerged as the European Medicines Agency (EMA) recommended approval of Waskyra (etuvetidigene autotemcel), the first gene therapy specifically designed to treat Wiskott-Aldrich syndrome…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More